Express Scripts has announced a plan to cut patient ... assurance programme” that the pharmacy benefit manager (PBM) is launching for members of participating non-government funded pharmacy ...

Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the agency’s July report on the PBM industry was biased and defamatory ...

Express Scripts also wants Khan to be recused from any actions that involve the company. The FTC's long-awaited report published in July was a difficult read for the PBM industry, concluding that ...

The suit against Eli Lilly, CVS Pharmacy, Express Scripts, Novo Nordisk, Sanofi-Aventis, Evernorth Health, CVS Caremark, UnitedHealth Group, OptumRx and others alleges the drugmakers were not ...

Kentucky’s attorney general is suing the pharmacy benefit manager (PBM) Express Scripts over its role in “worsening” the state’s opioid crisis. In the complaint filed in state court ...

"This case involves an unlawful price-fixing agreement among several PBMs—orchestrated by the PBM rate aggregator ... which ...

This was days after Express Scripts started the legal volleying with a federal lawsuit against the FTC, which accused the agency of making false and misleading claims about the PBM industry in a ...

GoodRx and pharmacy benefit managers CVS Caremark, Express Scripts, MedImpact and Navitus Health Solutions are facing class-action lawsuits accusing them of colluding to super press reimbursements to ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

For more than two years, Express Scripts fully cooperated with the FTC study into the PBM industry, meeting the agency's extensive demands for data and information. The FTC's report disregarded ...

On Tuesday, the healthcare company’s PBM, Express Scripts, sued the Federal Trade Commission over the agency’s recent report showing how the drug middlemen could be contributing to rising drug ...